Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-hodgkin’s lymphoma

By Sparano Joseph   Negassa Abdissa   Lansigan Erick   Locke Robin   Silva Chamath   Wiernik Peter  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 257-267

Humana Press, Inc

Access to resources Recommend Favorite

Lack of neuroprotection by an ACTH (4–9) analogue. A randomized trial in patients treated with vincristine for Hodgkin’s or non-Hodgkin’s lymphoma

By Koeppen S.   Verstappen C.   Körte R.   Scheulen M.   Strumberg D.   Postma T.   Heimans J.   Huijgens P.   Kiburg B.   Renzing-Köhler K.   Diener H.  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 3, 2004-03 ,pp. : 153-160

Springer Publishing Company

Access to resources Recommend Favorite

Clinical randomized comparative trial of DICE regimen and CHOP regimen in treating intermediate and high grade non-Hodgkin's lymphoma

By Wang Wenwu  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 107-110

Springer Publishing Company

Access to resources Recommend Favorite

Primary gastrointestinal non-Hodgkin’s lymphoma: clinicopathological and prognostic analysis

By Wang Tong   Gui Wei   Shen Quanliang  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 661-666

Humana Press, Inc

Access to resources Recommend Favorite

Primary non-Hodgkin’s lymphoma of the bone: A single institution experience

By Deshmukh C.   Bakshi A.   Parikh P.   Nair R.   Pai V.   Gupta S.   Shaikh A.   Muckaden M.   Naresh K.   Saikia T.  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 263-267

Humana Press, Inc

Access to resources Recommend Favorite